Cargando…
A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
A mouse‐human chimeric antibody for intercellular adhesion molecule‐1 (ICAM‐1) was established by using heavy chain loss mouse mutant hybridoma and human immunoglobulin expression vector. The HA58 hybridoma secreted anti‐ICAM‐1 monoclonal antibody (MoAb) (IgG1, k). The gene of the mouse variable reg...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921110/ https://www.ncbi.nlm.nih.gov/pubmed/8641973 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00237.x |
_version_ | 1783317940714602496 |
---|---|
author | Yamamura, Miyuki Hinoda, Yuji Sasaki, Shigeru Tsujisaki, Masayuki Oriuchi, Noboru Endo, Keigo Imai, Kohzoh |
author_facet | Yamamura, Miyuki Hinoda, Yuji Sasaki, Shigeru Tsujisaki, Masayuki Oriuchi, Noboru Endo, Keigo Imai, Kohzoh |
author_sort | Yamamura, Miyuki |
collection | PubMed |
description | A mouse‐human chimeric antibody for intercellular adhesion molecule‐1 (ICAM‐1) was established by using heavy chain loss mouse mutant hybridoma and human immunoglobulin expression vector. The HA58 hybridoma secreted anti‐ICAM‐1 monoclonal antibody (MoAb) (IgG1, k). The gene of the mouse variable region of heavy chain was amplified and cloned by the polymerase chain reaction technique directly from the HA58 hybridoma RNA. The variable region of heavy chain was joined with an expression vector which contains human γ1 constant gene. The expression vector was transfected into heavy chain loss mutant cells HA58‐7, which produced only murine immunoglobulin light chains. The resultant chimeric MoAb HA58, chHA58, retained full‐binding reactivity to ICAM‐1 compared with murine HA58 parental antibody. The chimeric MoAb chHA58 showed little antibody dependent cell‐mediated cytotoxic activity against cultured tumor cells. Biodistribution studies with (99m)Tc‐labeled chHA58 in nude mice bearing human gastric carcinoma JRST cells demonstrated that the tumor‐blood ratio was 1.55 at 18 h after injection, when the tumors were clearly visible in gamma scintigraphy. These data suggest that chHA58 may be of practical use for radioimmunoimaging of a wide variety of tumors. |
format | Online Article Text |
id | pubmed-5921110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59211102018-05-11 A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging Yamamura, Miyuki Hinoda, Yuji Sasaki, Shigeru Tsujisaki, Masayuki Oriuchi, Noboru Endo, Keigo Imai, Kohzoh Jpn J Cancer Res Article A mouse‐human chimeric antibody for intercellular adhesion molecule‐1 (ICAM‐1) was established by using heavy chain loss mouse mutant hybridoma and human immunoglobulin expression vector. The HA58 hybridoma secreted anti‐ICAM‐1 monoclonal antibody (MoAb) (IgG1, k). The gene of the mouse variable region of heavy chain was amplified and cloned by the polymerase chain reaction technique directly from the HA58 hybridoma RNA. The variable region of heavy chain was joined with an expression vector which contains human γ1 constant gene. The expression vector was transfected into heavy chain loss mutant cells HA58‐7, which produced only murine immunoglobulin light chains. The resultant chimeric MoAb HA58, chHA58, retained full‐binding reactivity to ICAM‐1 compared with murine HA58 parental antibody. The chimeric MoAb chHA58 showed little antibody dependent cell‐mediated cytotoxic activity against cultured tumor cells. Biodistribution studies with (99m)Tc‐labeled chHA58 in nude mice bearing human gastric carcinoma JRST cells demonstrated that the tumor‐blood ratio was 1.55 at 18 h after injection, when the tumors were clearly visible in gamma scintigraphy. These data suggest that chHA58 may be of practical use for radioimmunoimaging of a wide variety of tumors. Blackwell Publishing Ltd 1996-04 /pmc/articles/PMC5921110/ /pubmed/8641973 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00237.x Text en |
spellingShingle | Article Yamamura, Miyuki Hinoda, Yuji Sasaki, Shigeru Tsujisaki, Masayuki Oriuchi, Noboru Endo, Keigo Imai, Kohzoh A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title | A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title_full | A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title_fullStr | A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title_full_unstemmed | A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title_short | A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging |
title_sort | human/mouse chimeric monoclonal antibody against intercellular adhesion molecule‐1 for tumor radioimmunoimaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921110/ https://www.ncbi.nlm.nih.gov/pubmed/8641973 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00237.x |
work_keys_str_mv | AT yamamuramiyuki ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT hinodayuji ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT sasakishigeru ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT tsujisakimasayuki ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT oriuchinoboru ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT endokeigo ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT imaikohzoh ahumanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT yamamuramiyuki humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT hinodayuji humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT sasakishigeru humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT tsujisakimasayuki humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT oriuchinoboru humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT endokeigo humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging AT imaikohzoh humanmousechimericmonoclonalantibodyagainstintercellularadhesionmolecule1fortumorradioimmunoimaging |